Rhea J Posedel proposes sale of 15,000 shares (AEHR) — prior sales listed
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Rhea J Posedel reported a proposed sale of 15,000 common shares under Rule 144. The filing lists prior sales of 13,998 shares on 02/13/2026 for $390,404.22 and 30,000 shares on 04/09/2026 for $2,100,000.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 notice showing planned and recent insider sales.
The filing documents a proposed resale of 15,000 common shares and records two recent dispositions: 13,998 shares on 02/13/2026 for $390,404.22 and 30,000 shares on 04/09/2026 for $2,100,000. These are reporting items required for compliance with resale rules.
Cash‑flow treatment and whether sales were discretionary or pursuant to a prearranged plan are not stated in the excerpt; subsequent filings or broker confirmations would supply execution details.
Key Figures
Proposed sale: 15,000 shares
Prior sale: 13,998 shares
Prior sale: 30,000 shares
+1 more
4 metrics
Proposed sale
15,000 shares
proposed resale under Rule 144
Prior sale
13,998 shares
sold on 02/13/2026 for $390,404.22
Prior sale
30,000 shares
sold on 04/09/2026 for $2,100,000.00
Exchange / date
Nasdaq, 04/16/2026
listing venue and filing date shown in excerpt
Key Terms
Rule 144, common shares, issuer
3 terms
Rule 144 regulatory
"proposed sale of 15,000 common shares under Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
issuer financial
"compensation | issuer | 15000 | 11/28/2018"
FAQ
What does the AEHR Form 144 filed by Rhea J Posedel announce?
It announces a proposed sale of 15,000 common shares under Rule 144. The filing also lists two recent sales: 13,998 shares on 02/13/2026 for $390,404.22 and 30,000 shares on 04/09/2026 for $2,100,000.
Does the filing state whether the sales were part of a trading plan?
The provided excerpt does not state whether the transactions were executed under a Rule 10b5‑1 trading plan or other prearranged program. The filing lists dates, share counts, and proceeds for prior sales but offers no trading‑plan language.